Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Lubbock
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lubbock, TX

Studies commonly pay $75 to $4,500 per completed study

110 clinical trials are currently recruiting participants within 30 miles of Lubbock. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

110studies recruiting
4+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Lubbock right now

Top 25 of 110 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 762 participants sought
89bio Clinical Study Site — Lubbock, Texas (2.1 mi) · Sponsor: 89bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06419374)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought
Texas Retina Associates — Lubbock, Texas (2.1 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT05844982)

Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge

Penicillin Allergy Phase 3 Interventional 380 participants sought
Texas Tech University Health Sciences Center — Lubbock, Texas (2.1 mi) · Sponsor: James Tarbox, MD
See eligibility & contact on ClinicalTrials.gov (NCT06303128)

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04166409)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Breast Cancer N/A Observational 1,800 participants sought
Joe Arrington Cancer Research & Treatment Center — Lubbock, Texas (2.1 mi) · Sponsor: Exact Sciences Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06401421)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
Joe Arrington Cancer Research & Treatment Center — Lubbock, Texas (2.1 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06246916)

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis Phase 3 Interventional 751 participants sought
GI Alliance - Lubbock - Site Number: 8400092 — Lubbock, Texas (2.1 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07185009)

Mitochondrial DNA Signatures of Poor Aerobic Exercise Trainability in Young Adults Born Preterm

Preterm Birth N/A Interventional 60 participants sought
Texas Tech University | Kinesiology and Sport Management Building — Lubbock, Texas (2.1 mi) · Sponsor: Texas Tech University
See eligibility & contact on ClinicalTrials.gov (NCT06334107)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Lubbock, Texas (2.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Covenant Medical Center-Lakeside — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular Phase 3 Interventional 750 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03126916)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Peripheral Vascular Diseases N/A Observational 5,000 participants sought
Texas Tech University Health Sciences Center — Lubbock, Texas (2.1 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT04674969)

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 425 participants sought
Texas Digestive Disease Consultants-Lubbock powered by GI Alliance — Lubbock, Texas (2.1 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06819891)

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Arthritis, Psoriatic Phase 3 Interventional 600 participants sought
Clinical Site — Lubbock, Texas (2.1 mi) · Sponsor: MoonLake Immunotherapeutics AG
See eligibility & contact on ClinicalTrials.gov (NCT06641089)

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Phase 2 Interventional 461 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04546399)

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Diffuse Large B-Cell Lymphoma Phase 3 Interventional 1,046 participants sought
Joe Arrington Cancer Research and Treatment Center ( Site 0183) — Lubbock, Texas (2.1 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06717347)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought
89bio Clinical Study Site — Lubbock, Texas (2.1 mi) · Sponsor: 89bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06318169)
Actively enrolling

Studies you may be able to join near Lubbock

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Lubbock

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Texas Tech Physicians Internal Medicine Clinic

★ 4.9
3601 4th St, Lubbock, TX 79430
(806) 743-3150
"Dr Test is one of the nicest, most personable doctors that i have met in a long time."
— Rena Mashburn, 5★

Department of Internal Medicine Texas Tech University Health Sciences Center

★ 3.7
3601 4th St, Lubbock, TX 79430
(806) 743-3155
"If you don't see the little sign behind a large pillar that denotes where the line starts, and innocently stand in the wrong place, the much older, r…"
— Dan Hammons, 1★

Texas Tech University Health Sciences Center

Lubbock, TX 79415

Texas Tech Physicians: Dermatology

★ 4.9
Texas Tech University, Physicians Medical Pavilion, 3601 4th St 4th Floor, Lubbock, TX 79430
(806) 743-1842
"Dr. Alba Posligua, M.D., in the Texas Tech Physicians Dermatology Clinic provides ***EXCEPTIONAL*** quality care.<br><br>All of the staff were extrem…"
— Kelvin Meeks, 5★

Clinical trials in Lubbock: what's recruiting

The Lubbock area currently has 110 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lubbock, the most active research areas are:

  • Cancer & Oncology12 studies
  • Immune & Skin4 studies
  • Liver & Kidney3 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Lubbock, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lubbock

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lubbock participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Lubbock?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Lubbock, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Lubbock?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Lubbock?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Lubbock.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Lubbock typically complete one or two studies per year.

Paid clinical trials near Lubbock

Other metros within reach

Midland, TX18 Amarillo, TX99 Odessa, TX18 Fort Worth, TX619 Denton, TX383 Oklahoma City, OK641 Arlington, TX1,880 Killeen, TX107

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Lubbock Bladder Issues Due To Spinal Cord Injury in Lubbock All conditions

More of TX

Houston3,071 Pasadena3,014 Irving1,996 Grand Prairie1,964 Arlington1,880 Dallas1,877 Garland1,838 Plano1,830 Frisco1,829 Mesquite1,777 San Antonio1,010 Austin741

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts